Hera-MI brings AI to improve breast cancer early detection to increase recovery rate and to optimize healthcare treatment for women.
Breast Cancer is one of the leading cancer causes among women. However, when diagnosed early, patient can recover in almost 90% of cases.
Hera-MI is developing a clinical decision support system based on machine learning and medical imaging processing that improve breast cancer early detection. The system enhance diagnosis quality and accuracy while reducing radiologists interpretation time.
Moreover Hera-MI solution focuses on patient care improvement. With the more efficient breast cancer screening it allows women to be treated earlier and thus offers them higher chances for recovery.
Company Details
- Employees
- 25
- Founded
- -
- Address
- 4, Rue Duguay Trouin, Saint-Herblain,pays De La Loire 44800,france
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- hera-mi.com
- Keywords
- Breast Cancer, Mammography, Tomosynthesis, MRI, 3D Ultrasound, Elastography, software, Artificial Intelligence, Image Processing, Medical Imaging, Clinical Decision Support System, Senology, IA, Mammographie, CAD, sénologie, cancer du sein, tomosynthèse, AI.
- HQ
- Saint-Herblain, Pays de la Loire
Hera-Mi Questions
Hera-Mi's website is hera-mi.com
Hera-Mi's LinkedIn profile is https://fr.linkedin.com/company/hera-mi
Hera-Mi has
25 employees.
View email and phone details for 25
employees at Hera-Mi.
Hera-Mi's industry is
Software Development
Hera-Mi's top competitors are
Azmed,
Pixyl,
Icad,
Hera-Mi En,
Milvue,
Banook Imaging (Previously Keosys),
Intrasense,
Incepto,
Gleamer,
Therapixel.
Hera-Mi's categories are Software Development
Hera-Mi's founding year is 2017
